← Leaderboards
Robert Duncan Hite
Wake Forest University
$4,945,562
Attributed
$7,636,226
Total exposure
7
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2005–20$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$7,636,226 · 7
By mechanism
UM1$2,505,428 · 1
R01$1,837,171 · 1
N01$1,794,397 · 2
U01$1,481,818 · 1
M01$17,412 · 2
Top collaborators
- Thomas E Terndrup6 shared
- Alpha Alsbury Fowler3 shared
- Gregory S Martin3 shared
- Jonathon D Truwit3 shared
- Abhijit Duggal1 shared
- Henry E Wang1 shared
- Herbert P Wiedemann1 shared
Others in their field
Top investigators on “Research Personnel”
- David Heimbrook · Leidos Biomedical Research, Inc.$701,463,488
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Leonard Freedman · Leidos Biomedical Research, Inc.$557,978,666
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David R. Weir · University Of Michigan At Ann Arbor$364,053,504
- Judith S. Currier · University Of California Los Angeles$284,675,012
Research focus
Research PersonnelAdult Respiratory Distress SyndromeLungLung Injury, AcuteCytokineRecoveryBaseAcuteClinical ResearchProtocols DocumentationResourcesClinical TrialsNational Heart, Lung, And Blood InstituteMemberSepsisPatient PopulationCaringPreventEnrollmentCritical IllnessLung InjurySamplingMediator Of Activation ProteinNovel Strategies
Grant awards (24)
Ohio Consortium Clinical Center for the NHLBI Prevention and Early Treatment of A$204,806
U01 · FY2020 · HL
Ohio Consortium Clinical Center for the NHLBI Prevention and Early Treatment of A$219,299
U01 · FY2019 · HL
Ohio Consortium Clinical Center for the NHLBI Prevention and Early Treatment of A$219,301
U01 · FY2018 · HL · contact PI
Ohio Consortium Clinical Center for the NHLBI Prevention and Early Treatment of A$219,301
U01 · FY2017 · HL · contact PI
Vitamin C Infusion for Treatment in Sepsis Induced Acute Lung Injury (CITRIS-ALI)$853,679
UM1 · FY2016 · HL
Ohio Consortium Clinical Center for the NHLBI Prevention and Early Treatment of A$220,049
U01 · FY2016 · HL · contact PI
Ohio Consortium Clinical Center for the NHLBI Prevention and Early Treatment of A$238,411
U01 · FY2015 · HL · contact PI
Vitamin C Infusion for Treatment in Sepsis Induced Acute Lung Injury (CITRIS-ALI)$881,978
UM1 · FY2014 · HL
Ohio Consortium Clinical Center for the NHLBI Prevention and Early Treatment of A$160,651
U01 · FY2014 · HL · contact PI
Vitamin C Infusion for Treatment in Sepsis Induced Acute Lung Injury (CITRIS-ALI)$769,771
UM1 · FY2013 · HL
ARDS - SAILS Protocol$194,607
N01 · FY2012 · HL · contact PI
Treatment of Acute Lung Injury and Acute Respiratory Distress Syndrome$80,126
N01 · FY2012 · HL · contact PI
Phospholipase A2-mediated surfactant hydrolysis and dysfunction in ALI and ARDS$370,000
R01 · FY2011 · HL · contact PI
Treatment of Acute Lung Injury and Acute Respiratory Distress Syndrome$265,824
N01 · FY2011 · HL · contact PI
Treatment of Acute Lung Injury and Acute Respiratory Distress Syndrome$774,861
N01 · FY2010 · HL · contact PI
Phospholipase A2-mediated surfactant hydrolysis and dysfunction in ALI and ARDS$366,933
R01 · FY2010 · HL · contact PI
Phospholipase A2-mediated surfactant hydrolysis and dysfunction in ALI and ARDS$366,933
R01 · FY2009 · HL · contact PI
ARDS - EDEN Protocol$227,887
N01 · FY2009 · HL · contact PI
Phospholipase A2-mediated surfactant hydrolysis and dysfunction in ALI and ARDS$366,933
R01 · FY2008 · HL · contact PI
ARDS RO1$516
M01 · FY2008 · RR · contact PI
Phospholipase A2-mediated surfactant hydrolysis and dysfunction in ALI and ARDS$366,372
R01 · FY2007 · HL · contact PI
PAC VS CVC FOR MANAGEMENT OF ACUTE LUNG INJURY AND ARDS$11,423
M01 · FY2005 · RR
PAC vs CVC for Management of Acute Lung Injury and ARDS$5,473
M01 · FY2004 · RR
CLINICAL CENTER FOR ARDS$251,092
N01 · FY2001 · HR